4 Biotech Stocks To Consider Buying, 2 To Sell In 2012
Seeking Alpha
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
- Amag Pharmaceuticals
- Amarin
- Arena
- Ariad
- Biogen Idec
- Biomarin
- Celgene
- Clovis Oncology
- Dendreon
- Geron
- Gilead
- Human Genome Sciences
- Immunogen
- Incyte
- Indenix
- InterMune
- Keryx
- MannKind
- Medivation
- Merck KGaA
- Mesoblast
- ONYX Pharmaceuticals
- Regeneron
- Roche
- Seattle Genetics
- Spectrum Pharmaceuticals
- Vertex
- Vivus
- YM BioSciences
10 Biotech Stock Predictions for 2012
TheStreet.com
Spectrum Turns Neglected Cancer Drugs Into Cash Cows
Investors.com

